Antibiotics

Recent Rosacea Blog Posts

Zilxi to launch at $485 for 30gm canister

The publicity around the launch for Zilxi, the new 1.5% topical minocycline based treatment for rosacea contains confirmation that the list price for a 30gm prescription will be $485. Now known as VYNE Therapeutics, the makers of Zilxi are preparing to make their recently FDA approved treatment for the papules and pustules of rosacea available […]

Continue Reading

Zilxi 1.5% Topical Minocycline Foam for rosacea lesions

Zilxi, 1.5% Topical Minocycline Foam has been approved for the treatment of the papules and pustules of rosacea in adults. From the Press Release “ZILXI (minocycline) topical foam, 1.5% is a topical form of the antibiotic minocycline for the treatment of adults with pimples and bumps caused by a condition called rosacea. ZILXI is available […]

Continue Reading

BioPharmX developing topical Minocycline Gel 1%

A phase 2 trial for a topical minocycline gel for the papules and pustules of rosacea has just been listed. BiopharmX, the sponsors of the trial, suggest that the product BPX-04 has “good tolerability and promising efficacy in rosacea” and also showcases “the value of our anhydrous hydrophilic topical delivery system.” The trial will compare the […]

Continue Reading

Promius files NDA for modified release tetracycline Zenavod (DFD-09)

Promius Pha rma, a subsidiary of Dr. Reddy’s Laboratory has filed a New Drug Application for a modified release tetracycline for the treatment of rosacea. Promius is calling their new drug DFD-09. Promius Pharma is probably best know to rosacea sufferers via the availability of Promiseb Topical Cream in the US. Promiseb, a treatment for […]

Continue Reading

Gladskin Rosacea Cream and Gel, Staphefekt in a topical

Seeking to create products based on the recently publicised MRSA-killing topical Staphefekt are some topical creams to treat rosacea, acne, eczema and general skin irritation.

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.